-
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-upB Bikdeli, MV Madhavan, D Jimenez et al. -
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm SocietyCT January, LS Wann, H Calkins et al.
-
Effect of Aspirin on All-Cause Mortality in the Healthy ElderlyMcNeil JJ, Nelson MR, ASPREE Investigator Group.
-
Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?Wehner GJ, Jing L, Haggerty CM et al.
-
Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trialM Mancone, R Cavalcante, PW Serruys et al.
-
Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart AssociationLY Chen, MK Chung, LA Allen et al.
-
Routine Continuous Electrocardiographic Monitoring Following Percutaneous Coronary InterventionsMA Al-Hijji , R Gulati，M Singh et al.
-
Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery OcclusionsH Kawashima , K Takahashi , the SYNTAX Extended Survival Investigators et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
